Duquesne Family Office

“Iambic would raise around $160 million at a $900 million valuation were it to price at the top of its IPO range, after having raised around $350 million from venture capital firms.”

“Around $60 million of the IPO shares would be purchased by Stan Druckenmiller's Duquesne Family Office and existing investor Cathie Wood's ARK Investment Management.”

“Ratio Therapeutics...raised a $70 million Series C from investors including Duquesne Family Office, Bristol Myers Squibb and Catalio Capital Management.”